15576 Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 

collects and processes this report on 

behalf of all three agencies. 

Request for Comment 

Public comment is requested on all 

aspects of this notice. Comment is also 

specifically invited on: 

a. Whether the information collection 

is necessary for the proper performance 

of the agencies’ functions, including 

whether the information has practical 

utility; 

b. The accuracy of the agencies’ 

estimate of the burden of the 

information collection, including the 

validity of the methodology and 

assumptions used; 

c. Ways to enhance the quality, 

utility, and clarity of the information to 

be collected; 

d. Ways to minimize the burden of the 

information collection on respondents, 

including through the use of automated 

collection techniques or other forms of 

information technology; and 

e. Estimates of capital or start up costs 

and costs of operation, maintenance, 

and purchase of services to provide 

information. 

Comments submitted to the Board in 

response to this notice will be shared 

with the other agencies. All comments 

will become a matter of public record. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2024–04398 Filed 3–1–24; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF DEFENSE 

GENERAL SERVICES 

ADMINISTRATION 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[OMB Control No. 9000–0205; Docket No. 

2023–0053; Sequence No. 11] 

Submission for OMB Review; 

Implementation of Federal Acquisition 

Supply Chain Security Act (FASCSA) 

Orders 

AGENCY: Department of Defense (DOD), 

General Services Administration (GSA), 

and National Aeronautics and Space 

Administration (NASA). 

ACTION: Notice. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division has 

submitted to the Office of Management 

and Budget (OMB) a request to review 

and approve an extension of a 

previously approved information 

collection requirement regarding 

implementation of Federal Acquisition 

Supply Chain Security Act (FASCSA) 

Orders. 

DATES: Submit comments on or before 

April 3, 2024. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 30 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. 

FOR FURTHER INFORMATION CONTACT: 

Marissa Ryba, Procurement Analyst, at 

telephone 314–586–1280, or marissa.

ryba@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. OMB Control Number, Title, and 

Any Associated Form(s) 

9000–0205, Implementation of 

Federal Acquisition Supply Chain 

Security Act (FASCSA) Orders. 

B. Need and Uses 

This clearance covers the information 

that offerors and contractors must 

submit to comply with the following 

FAR requirements: 

a. FAR 52.204–29, Federal 

Acquisition Supply Chain Security Act 

Orders—Representation and 

Disclosures. This provision prohibits 

contractors from providing or using as 

part of the performance of the contract 

any covered article, or any products or 

services produced or provided by a 

source, if the covered article or the 

source is subject to an applicable 

FASCSA order identified in the clause 

at FAR 52.204–30(b)(1). 

By submitting an offer, offerors are 

representing compliance with the 

prohibition. If an offeror cannot 

represent compliance with the 

prohibition, then the offeror must 

disclose the following information in 

accordance with 52.204–29(e): 

(1) Name of the product or service 

provided to the Government; 

(2) Name of the covered article or 

source subject to an FASCA order; 

(3) If applicable, name of the vendor, 

including the Commercial and 

Government Entity code and unique 

entity identifier (if known), that 

supplied the covered article or the 

product or service to the Offeror; 

(4) Brand; 

(5) Model number (original equipment 

manufacturer number, manufacturer 

part number, or wholesaler number); 

(6) Item description; 

(7) Reason why the applicable 

covered article or the product or service 

is being provided; 

b. FAR 52.204–30, Federal 

Acquisition Supply Chain Security Act 

Orders—Prohibition. This clause 

requires contractors to provide a report 

to the Government within 3 business 

days if the contractor identifies that the 

contractor or any-tier subcontractor, 

delivered or used a covered article or 

product or service subject to a FASCSA 

order. The report requires the following 

information: 

(1) Contract number; 

(2) Order number(s), if applicable; 

(3) Name of the product or service 

provided to the Government; 

(4) Name of the covered article or 

source subject to a FASCSA order; 

(5) If applicable, name of the vendor, 

including the Commercial and 

Government Entity code and unique 

entity identifier (if known), that 

supplied the covered article or the 

product or service to the Contractor; 

(6) Brand; 

(7) Model number (original equipment 

manufacturer number, manufacturer 

part number, or wholesaler number); 

(8) Item description; and 

(9) Any readily available information 

about mitigation actions undertaken or 

recommended. 

The contractor must also submit 

additional information within 10 days 

of submitting the first report identifying 

any further available information about 

mitigation actions undertaken or 

recommended. Additionally, the 

contractor shall describe the efforts it 

undertook to prevent submission and 

any additional efforts to prevent future 

submission of the covered article or the 

product or service produced or provided 

by a source subject to an applicable 

FASCSA order. 

FAR provision 52.204–29. 

Information collected under will be by 

the government to determine whether to 

seek a waiver from a FASCSA order 

issued under the authority of the 

Federal Acquisition Supply Chain 

Security Act of 2018. 

FAR clause 52.204–30 will 

Information collected will be used by 

the contracting officer working with the 

requirement activity to determine 

whether it is necessary to take further 

action and modify the contract. 

C. Annual Burden 

Respondents: 6,113. 

Total Annual Responses: 1. 

Total Burden Hours: 12,226. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 88 FR 88923, on 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 15577 

December 26, 2023. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division, by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0205, Implementation 

of Federal Acquisition Supply Chain 

Security Act (FASCSA) Orders. 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2024–04505 Filed 3–1–24; 8:45 am] 

BILLING CODE 6820–EP–P 

UNITED STATES AGENCY FOR 

GLOBAL MEDIA 

Fiscal Year (FY) 2022 Service Contract 

Inventory Report & FY 2023 Planned 

Analysis 

AGENCY: United States Agency for 

Global Media. 

ACTION: Notice. 

SUMMARY: The United States Agency for 

Global Media (USAGM) announces the 

members of its FY 2022 Service Contract 

Inventory Report and FY 2023 Planned 

Analysis. 

ADDRESSES: USAGM Office of Contracts, 

330 Independence Ave. SW, 

Washington, DC 20237. 

FOR FURTHER INFORMATION CONTACT: 

Khilena Adhin, Acquisition Policy 

Branch Chief, at conpolicy@usagm.gov, 

202–920–2302. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 743 of division 

C of the Consolidated Appropriations 

Act of 2010, the U.S. Agency for Global 

Media (USAGM) is publishing this 

notice to advise the public of the 

availability of its FY 2022 Service 

Contract Inventory Report and FY 2023 

Planned Analysis. They are available on 

the USAGM website, through the 

following link: https://www.usagm.gov/ 

our-work/strategy-and-results/strategicpriorities/research-reports/servicecontract-inventory/. The service contract 

inventory provides information on 

service contract actions over $25,000 

made in FY 2022. The information is 

organized by function to show how 

contracted resources are distributed 

throughout the Agency. The inventory 

has been developed in accordance with 

guidance on service contract inventories 

issued on November 5, 2010 and on 

December 19, 2011 by the Office of 

Management and Budget, Office of 

Federal Procurement Policy (OFPP). 

Dated: February 28, 2024. 

Armanda Matthews, 

Program Support Specialist, U.S. Agency for 

Global Media. 

[FR Doc. 2024–04475 Filed 3–1–24; 8:45 am] 

BILLING CODE 8610–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Clinical Laboratory 

Improvement Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting for the Clinical 

Laboratory Improvement Advisory 

Committee (CLIAC). This is a virtual 

meeting. It is open to the public, limited 

only by the number of webcast lines 

available. Time will be available for 

public comment, and the public is also 

welcome to submit written comments in 

advance of the meeting (see the public 

participation section below). 

DATES: The meeting will be held on 

April 10, 2024, from 10 a.m. to 6 p.m., 

EDT. 

ADDRESSES: This is a virtual meeting. 

Meeting times are tentative and subject 

to change. The confirmed meeting 

times, agenda items, and meeting 

materials, including instructions for 

accessing the live meeting broadcast, 

will be available on the CLIAC website 

at https://www.cdc.gov/cliac. Check the 

website on the day of the meeting for 

the web conference link. 

FOR FURTHER INFORMATION CONTACT: 

Heather Stang, M.S., Senior Advisor for 

Clinical Laboratories, Division of 

Laboratory Systems, Center for 

Laboratory Systems and Response, 

Office of Laboratory Science and Safety, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, 

Mailstop V24–3, Atlanta, Georgia 

30329–4027. Telephone: (404) 498– 

2769; Email: HStang@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Clinical Laboratory 

Improvement Advisory Committee 

(CLIAC) is charged with providing 

scientific and technical advice and 

guidance to the Secretary, Department 

of Health and Human Services; the 

Assistant Secretary for Health; the 

Director, Centers for Disease Control 

and Prevention (CDC); the 

Commissioner, Food and Drug 

Administration (FDA); and the 

Administrator, Centers for Medicare & 

Medicaid Services (CMS). The advice 

and guidance pertain to general issues 

related to improvement in clinical 

laboratory quality and laboratory 

medicine and specific questions related 

to possible revision of the Clinical 

Laboratory Improvement Amendments 

of 1988 (CLIA) standards. Examples 

include providing guidance on studies 

designed to improve quality, safety, 

effectiveness, efficiency, timeliness, 

equity, and patient-centeredness of 

laboratory services; revisions to the 

standards under which clinical 

laboratories are regulated; the impact of 

proposed revisions to the standards on 

medical and laboratory practice; and the 

modification of the standards and 

provision of non-regulatory guidelines 

to accommodate technological 

advances, such as new test methods, the 

electronic transmission of laboratory 

information, and mechanisms to 

improve the integration of public health 

and clinical laboratory practices. 

Matters to be Considered: The agenda 

will include agency updates from CDC, 

CMS, and FDA. Presentations and 

CLIAC discussions will focus on the 

applicability of CLIA personnel 

requirements to preanalytic testing, the 

role of artificial intelligence and 

machine learning in the clinical 

laboratory, and the use of clinical 

standards to improve laboratory quality. 

Agenda items are subject to change as 

priorities dictate. 

Public Participation 

It is the policy of CLIAC to accept 

written public comments and provide a 

brief period for oral public comments 

pertinent to agenda items. 

Oral Public Comment: Public 

comment periods for each agenda item 

are scheduled immediately prior to the 

Committee discussion period for that 

item. In general, each individual or 

group requesting to present an oral 

comment will be limited to a total time 

of five minutes (unless otherwise 

indicated). Speakers should email 

CLIAC@cdc.gov or notify the contact 

person above (see FOR FURTHER

INFORMATION CONTACT) at least five 

business days prior to the meeting date. 

Written Public Comment: CLIAC 

accepts written comments until the date 

of the meeting (unless otherwise stated). 

However, it is requested that comments 

be submitted at least five business days 

prior to the meeting date so that the 


khammond on DSKJM1Z7X2PROD with NOTICES